Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by panimjon Jan 30, 2018 6:21pm

179 Views

Post# 27466584

RE:RE:RE:RE:RE:No support - it will slide to .15

This guy is a tool saying MJ stocks are over inflated
most MJ companies haven’t even gotten started
They are trying to establish them self’s buying land getting their licences
and most are just penny stocks. Not to say when they do produce
they wont fall and stabilize till at least a few quarters or longer
making profit after every quarter, and let’s not forget
the takeovers that are going to take place.
so this tool on the video is ahead of himself way ahead

Bullboard Posts

Sirios Resource discovers visible gold in Quebec